Inflammatory indices associated with increased chronic kidney disease risk in coronary artery disease cohort.
A Simple Blood Test Could Predict Kidney Disease Risk in Heart Patients
This cohort study of 5181 patients with coronary artery disease examined inflammatory markers. All four indices showed significant associati…
A common blood test could warn heart patients about their kidney risk years before damage starts.
Diabetes Prevalence and Clinical Correlates in Hospitalized Heart Failure Patients in China
Diabetes is common in hospitalized heart failure patients in China.
This retrospective cohort study of 2,008 adults hospitalized with heart failure in China found a 23.21% prevalence of diabetes. Female sex, …
In a study of 2,008 hospitalized heart failure patients in China, 23.21% had diabetes, and certain factors like female sex and higher blood …
Admission HbA1c and In-Stent Restenosis in CAD Patients After PCI
One blood sugar measure linked to repeat heart procedures
This retrospective observational cohort study assessed admission glycated hemoglobin (HbA1c) levels and in-stent restenosis (ISR) in 6,297 C…
In nearly 6,300 heart patients who had a stent, one blood sugar measure was tied to a higher chance of needing another procedure to clear th…
Higher ZJU index associated with worse metabolic profiles in adults with type 2 diabetes and hyperuricemia
</think>
This retrospective cross-sectional analysis of 1772 adults with type 2 diabetes mellitus evaluated the association between the Zhejiang Univ…
A simple calculation used for liver health may also warn about uric acid problems in diabetes.
Higher Plasma Aldosterone Linked to 51% Increased CVD Risk in Hypertensive Patients
High aldosterone levels raise heart attack and stroke risk in patients with high blood pressure.
A cohort study of 8653 hypertensive patients found that higher plasma aldosterone concentration (PAC) was associated with a 51% increased ri…
Patients with high blood pressure and elevated aldosterone had a 51% higher risk of heart disease over five years.
Progesterone exposure duration affects live birth rates depending on blastocyst expansion stage in frozen embryo transfers.
Progesterone Timing Doubles IVF Success for Some
This retrospective cohort study evaluated 2,058 women undergoing single frozen–thawed day-6 blastocyst transfer. Results showed no overall d…
You’ve waited weeks. Maybe years. You’ve tracked your cycle, taken injections, and held your breath through every step.
Observational Study Evaluating Hospital-Based Chronic Disease Management Platform in Adults With Type 2 Diabetes
Diabetes Control Improves With This Simple Change
This retrospective observational study evaluated adults with type 2 diabetes enrolled in a hospital-based chronic disease management platfor…
It starts with a
Tirzepatide MTD Demonstrates Cost-Effectiveness Versus Semaglutide MTD in Obesity Simulation Modeling Study
Tirzepatide Saves Money and Health Over Semaglutide
This simulation modeling study using Phase-3 trial data evaluated tirzepatide versus semaglutide in individuals with obesity or overweight w…
Imagine standing in a doctor's office, facing a choice between two powerful weight-loss medicines.
Network meta-analysis on stem cell therapy for osteonecrosis of the femoral head
Higher Dose of Own Stem Cells May Protect Hip Bones Better Than Standard Surgery
This systematic review and network meta-analysis synthesized evidence from 18 studies involving 1,192 patients with osteonecrosis of the fem…
For patients with a collapsing hip bone, adding a high dose of their own stem cells to a common surgery may delay or prevent the need for a …
Meta-analysis of adjunctive SGLT2 inhibitors in type 1 diabetes shows mixed safety and efficacy signals.
No More Bone Fear With New Diabetes Drug
This meta-analysis evaluated adjunctive SGLT2 inhibitor therapy in 6,731 patients with type 1 diabetes mellitus receiving insulin-based ther…
Many people with type 1 diabetes worry about their bones.
Secukinumab 300 mg subcutaneously failed to demonstrate overall response in adults with active Graves orbitopathy versus placebo.
Secukinumab showed no benefit for active Graves orbitopathy patients
This randomized, double-blind, placebo-controlled trial evaluated secukinumab versus placebo in 28 adults with active, moderate-to-severe, n…
Secukinumab treatment for Graves orbitopathy showed no improvement in symptoms or eye measurements compared to placebo treatment.
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT.
Diabetes Weakens Bones: One Drug Builds Them Back
This pilot randomized controlled trial evaluated antiresorptive and anabolic agents in 129 postmenopausal women with Type 2 Diabetes. Teripa…
Building new bone tissue with a specific daily shot works better than just protecting existing bone for women with diabetes.